Integra LifeSciences (IART) Competitors

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Which has more volatility & risk, ITGR or IART?

Integer has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in ITGR or IART?

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.2% of Integer shares are held by insiders. Comparatively, 3.5% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Does the media favor ITGR or IART?

In the previous week, Integer had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for Integer and 2 mentions for Integra LifeSciences. Integer's average media sentiment score of 0.57 beat Integra LifeSciences' score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is ITGR or IART more profitable?

Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	4.61%	12.27%	6.23%
Integra LifeSciences	-30.87%	12.15%	4.32%

Do analysts prefer ITGR or IART?

Integer currently has a consensus target price of $137.29, indicating a potential upside of 30.92%. Integra LifeSciences has a consensus target price of $16.17, indicating a potential upside of 7.21%. Given Integer's stronger consensus rating and higher possible upside, equities analysts clearly believe Integer is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
Integra LifeSciences	4 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.75

Which has preferable valuation and earnings, ITGR or IART?

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.79B	2.05	$119.90M	$2.27	46.20
Integra LifeSciences	$1.61B	0.73	-$6.94M	-$6.53	-2.31

Summary

Integer beats Integra LifeSciences on 15 of the 17 factors compared between the two stocks.